Current Liabilities: The sum of all liabilities classified as current for having maturities of less than one year.
AgomAb Therapeutics NV (AGMB) had Current Liabilities of 21.03M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-87.68M |
|
-- |
|
-- |
|
67.06M |
|
-67.06M |
|
-3.70M |
|
-70.77M |
|
-70.77M |
|
-70.77M |
|
-70.77M |
|
-70.77M |
|
-70.77M |
|
-67.06M |
|
-66.82M |
|
0.54M |
|
0.54M |
|
-162.04 |
|
-162.04 |
|
| Balance Sheet Financials | |
137.17M |
|
0.57M |
|
36.74M |
|
173.90M |
|
|
Current Liabilities |
21.03M |
1.14M |
|
4.77M |
|
25.80M |
|
148.10M |
|
115.61M |
|
148.10M |
|
0.54M |
|
| Cash Flow Statement Financials | |
-58.54M |
|
-37.34M |
|
-0.38M |
|
193.99M |
|
97.77M |
|
-96.22M |
|
6.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.52 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-58.54M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-47.78% |
|
-61.21% |
|
-40.69% |
|
-47.42% |
|
273.69 |
|
-108.19 |
|
-108.18 |
|